(firstQuint)Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis.

 This is a multicenter, open label study of the long-term safety of IDP-118 Lotion in subjects with plaque psoriasis.

 To be eligible for the study, subjects must be at least 18 years of age and have a clinical diagnosis of moderate to severe plaque psoriasis (defined as an Investigator's Global Assessment [IGA] score of 3 or 4).

.

 Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis@highlight

The objective of this study is to evaluate the long-term safety of IDP-118 Lotion.

